Skip to content

Reimbursement & Coding of CytoSorb Therapy

You can find out here in which countries CytoSorb therapy can be specifically coded and billed. For information on countries not listed here, please contact us.

Coding of COVID-19 patients

WHO has assigned a temporary diagnoses code for COVID-19 patients: ICD U07.1.
• U07.1 COVID-19, virus identified by laboratory test and
• U07.2 COVID-19, virus not identified

Please select:

OPS Code 2020 zur KostenerstattungCoding of CytoSorb

The CytoSorb therapy is coded with the procedure code 8-821.2 “Extracorporeal adsorption of low and medium sized molecular, hydrophobic substances (including cytokine adsorption)”.

>> Link to the OPS Code Catalog 2020 of the DIMDI

Reimbursement of CytoSorb

According to Appendix 6 of the current German DRG catalogue, the OPS code 8-821.2 is assigned the individually, annually negotiable additional reimbursement ZE2020-09.

Please note that the additional reimbursement ZE2020-09 is split into two treatment procedures that are assigned to it; on the one hand, classic hemoperfusion (e.g., with activated charcoal filters), documented by OPS code 8-856. On the other hand, the CytoSorb therapy to be coded by OPS code 8-821.2. For easier budget negotiations, differentiation and documentation of the different reimbursement rates, the reimbursement code could be extended by a letter, for example:

ZE code           OPS code
ZE2020-09-a    8-821.2 Extracorporeal adsorption of low and medium sized molecular, hydrophobic substances
ZE2020-09-b    8-856 Hemoperfusion

>> Link to the German DRG catalog 2020 at InEK

Coding

The CytoSorb therapy has been coded since January 1, 2017 via the OPS code 8-821.2 “Extracorporeal adsorption of low and medium molecular weight, hydrophobic substances (including cytokine adsorption)”.

>> Link to the OPS Code Catalog 2019 of the DIMDI
>> Link to the OPS Code Catalog 2018 of the DIMDI

Reimbursement

The OPS code 8-821.2 is subject to the separately negotiable additional fee ZE2019-09 (in 2019) acc. Annex 6 of the case flat rate catalog.

Please note that the additional charge ZE2019-09 has two treatment procedures assigned to it; on the one hand, classic hemoperfusion (e.g., with activated charcoal filters), code OPS code 8-856; second, the CytoSorb therapy, to be coded with the OPS code 8-821.2. For easier negotiation, differentiation and documentation of the different charges, the additional charge code can, for example, be supplemented with a letter, for example:

ZE code           OPS code
ZE2019-09-a    8-821.2 Extracorporeal adsorption of low and medium sized molecular, hydrophobic substances
ZE2019-09-b    8-856 Hemoperfusion

>> Link to the German DRG catalog 2019 at InEK
>> Link to the case fee catalog 2018 at InEK

Coding

The CytoSorb therapy has been coded since January 1, 2017 via the OPS code 8-821.2 “Extracorporeal adsorption of low and medium molecular weight, hydrophobic substances (including cytokine adsorption)”.

>> Link to the OPS Code Catalog 2018 of the DIMDI

Reimbursement

The OPS code 8-821.2 is subject to the separately negotiable additional fee ZE2019-09 (in 2019) acc. Annex 6 of the case flat rate catalog.

Please note that the additional charge ZE2019-09 has two treatment procedures assigned to it; on the one hand, classic hemoperfusion (e.g., with activated charcoal filters), code OPS code 8-856; second, the CytoSorb therapy, to be coded with the OPS code 8-821.2. For easier negotiation, differentiation and documentation of the different charges, the additional charge code can, for example, be supplemented with a letter, for example:

Coding
Since 01.01.2017, the OPS code 8-821.2 applied by the medical societies applies. Extracorporeal adsorption of low and medium molecular weight, hydrophobic substances (including cytokine adsorption).
>> Link to the OPS-Code Catalog of the DIMDI

Reimbursement

This OPS code is the additional fee to be negotiated individually ZE2017-09 (Attention: not ZE2017-13!) Gem. Annex 6 of the case flat rate catalog 2017 assigned. Due to an initiative of several professional societies, the additional fee was added to the catalog at the end of 2016.
In accordance with §5 KHEntgG you will receive a lump-sum payment of 600.00 EUR before the additional fee is negotiated. After the negotiation, the difference between the lump sum and the negotiated additional fee for the cases treated in the meantime will be reimbursed.
>> Link to the case flat rate catalog 2017 of the InEK

NUB application 2017

Once the additional fee has been included in the flat rate catalog 2017, there is no longer any basis for a separate budget via a NUB application. Therefore, InEK awarded status 2 at the end of January. We would like to thank all 251 clinics who have submitted this application!
>> List of NUB applications 2017 at the InEK

The CytoSorb therapy will be coded from January 1, 2019 via the CHOP Code Z99.76.12 “Adsorption of cytokines (adsorption of interleukins)”.

In version 2019 of the Swiss Operative Classification, subcategory 99.76.- “Extracorporeal immunoadsorption and adsorption of inflammatory substances” was mentioned. Code 99.76.12 added. The subcategory title 99.76.- was adapted from “Extracorporeal immunoadsorption” to “Extracorporeal immunoadsorption and adsorption of inflammatory substances”.

In all applications that do not focus on cytokine removal but, for example, the removal of bilirubin (liver failure) or myoglobin (rhabdomyoyse), CytoSorb therapy is correctly identified with the CHOP code 99.76.19 “Extracorporeal immunosorbing, other” encoded

>> Swiss Operational Classification (CHOP) 2019 of the FSO

>> Download Flyer Switzerland